CreaVax-RCC (JW CreaGene)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCreaVax-RCC (JW CreaGene)

Drug Alias NameCreaVax-RCC

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Renal Cell

Global Approved IndicationsCarcinoma, Renal Cell

Approved Indications in ChinaN/A

Original Approved Country/TerritorySouth Korea

Original Approved Date2007/01/01

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesJw Creagene Corp

China Registration ClassN/A

Develop Information

Active CompaniesJw Creagene Corp

Inactive CompaniesN/A

Active IndicationsCarcinoma, Renal Cell

Inactive IndicationsN/A

Other Information

ATC CodeJ07X